A 2024 cost-effectiveness analysis in JAMA Network Open found that tirzepatide at retail prices is not cost-effective at standard willingness-to-pay thresholds for weight loss alone
Lead researcher Daniel Lyons, St Vincents University Hospital, Dublin, Ireland, highlighted that while semaglutides weight-loss effects are known, its impact on reducing HS flare-ups is promising
As a result, people shed pounds by eating less
In many cases, heart palpitations improve as your body adjusts to treatment
Untreated sleep apnea is associated with long-term complications, including high blood pressure, cardiovascular disease, heart attack, and stroke